Weidinger, S., Pink, A., Francisco, J., Kurbasic, A., Olsen, C., Vilsbøll, A., & de Bruin Weller, M. (2020). Tralokinumab Improves Clinically Relevant Outcome Measures: A Post Hoc Analysis of ECZTRA 3, A Randomized Clinical Trial in Patients with Moderate-To-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, 4(6), s100. https://doi.org/10.25251/skin.4.supp.100